Malta - English - Medicines Authority

sanofi malta limited - dimeticone; aluminium hydroxide; magnesium hydroxide - chewable tablet - dimeticone 25 mg; aluminium hydroxide 200 mg; magnesium hydroxide 200 mg - drugs for acid related disorders

Malta - English - Medicines Authority

sanofi malta limited - dimeticone; aluminium hydroxide; magnesium hydroxide - oral suspension - dimeticone 25 mg; aluminium hydroxide 114 mg; magnesium hydroxide 200 mg - drugs for acid related disorders

Malta - English - Medicines Authority

sanofi s.r.l viale l. bodio, 37/b 20158, milan, italy - dimeticone, aluminium oxide, hydrated, magnesium hydroxide - chewable tablet - dimeticone 25 milligram(s) ; aluminium oxide, hydrated 200 milligram(s) ; magnesium hydroxide 200 milligram(s) - drugs for acid related disorders

Malta - English - Medicines Authority

wallace manufacturing chemists limited - dimethicone, activated, aluminium hydroxide, magnesium hydroxide - oral suspension - dimethicone, activated 25 milligram(s) ; aluminium hydroxide 220 milligram(s) ; magnesium hydroxide 200 milligram(s) - drugs for functional gastrointestinal disorders

Malta - English - Medicines Authority

opella healthcare france sas t/a sanofi 157 avenue charles de gaulle, 92200 neuilly-sur-seine , france - dimeticone, aluminium oxide, hydrated, magnesium hydroxide - chewable tablet - dimeticone 25 mg aluminium oxide, hydrated 200 mg magnesium hydroxide 200 mg - drugs for acid related disorders

New Zealand - English - Medsafe (Medicines Safety Authority)

boots healthcare new zealand limited - aluminium hydroxide gel dried 84 mg/ml; dimeticone 25 mg/ml; magnesium oxide 14 mg/ml - oral suspension - 420mg,125mg,70mg/5ml - active: aluminium hydroxide gel dried 84 mg/ml dimeticone 25 mg/ml magnesium oxide 14 mg/ml

Ireland - English - HPRA (Health Products Regulatory Authority)

ssl international plc - magnesium oxidum leve aluminium hydroxide dimethicone 350 - oral suspension

Ireland - English - HPRA (Health Products Regulatory Authority)

sanofi-aventis ireland limited t/a sanofi - aluminium oxide, hydrated ph. eur; magnesium hydroxide ph. eur.; dimeticone ph. eur. (as simeticone ph. eur.) - chewable tablet - 200mg/200mg/25 milligram(s) - antacids with antiflatulents; ordinary salt combinations and antiflatulents

Australia - English - Department of Health (Therapeutic Goods Administration)

johnson & johnson pacific pty ltd - simethicone, quantity: 6 mg/ml; aluminium hydroxide, quantity: 80 mg/ml; magnesium hydroxide, quantity: 80 mg/ml; magnesium hydroxide, quantity: 50.1383 mg/ml; aluminium hydroxide hydrate, quantity: 36.8664 mg/ml - oral liquid, suspension - excipient ingredients: purified water; butyl hydroxybenzoate; xanthan gum; ethyl hydroxybenzoate; xylitol; ethanol; sorbitol solution (70 per cent) (non-crystallising); acesulfame potassium; propyl hydroxybenzoate; flavour; dimeticone 100; peg-4 stearate; glyceryl distearate; peg-3 distearate; peg-20 stearate; simethicone; sorbic acid; hydrogen peroxide - relief from indigestion, heartburn, upset stomach, flatulence and wind pain.

Australia - English - Department of Health (Therapeutic Goods Administration)

johnson & johnson pacific pty ltd - simethicone, quantity: 4 mg/ml; aluminium hydroxide, quantity: 40 mg/ml; magnesium hydroxide, quantity: 40 mg/ml - oral liquid, suspension - excipient ingredients: ethyl hydroxybenzoate; xanthan gum; xylitol; purified water; sorbitol solution (70 per cent) (non-crystallising); butyl hydroxybenzoate; ethanol; propyl hydroxybenzoate; acesulfame potassium; flavour; dimeticone 100; peg-4 stearate; glyceryl distearate; peg-3 distearate; peg-20 stearate; simethicone; sorbic acid; hydrogen peroxide - relief from indigestion, heartburn, upset stomach, flatulence and wind pain.